259 related articles for article (PubMed ID: 19246537)
1. Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis.
Zhao Z; Zhao C; Zhang XH; Zheng F; Cai W; Vlassara H; Ma ZA
Endocrinology; 2009 Jun; 150(6):2569-76. PubMed ID: 19246537
[TBL] [Abstract][Full Text] [Related]
2. IL-1β hampers glucose-stimulated insulin secretion in Cohen diabetic rat islets through mitochondrial cytochrome c oxidase inhibition by nitric oxide.
Weksler-Zangen S; Aharon-Hananel G; Mantzur C; Aouizerat T; Gurgul-Convey E; Raz I; Saada A
Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E648-57. PubMed ID: 24425765
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products downregulate glucokinase in mice.
Jung H; Joo J; Jeon Y; Lee J; In J; Kim D; Kang E; Kim Y; Lim Y; Kang J; Choi J
Diabetes Metab Res Rev; 2011 Sep; 27(6):557-63. PubMed ID: 21538775
[TBL] [Abstract][Full Text] [Related]
4. Nε-(carboxymethyl) lysine-induced mitochondrial fission and mitophagy cause decreased insulin secretion from β-cells.
Lo MC; Chen MH; Lee WS; Lu CI; Chang CR; Kao SH; Lee HM
Am J Physiol Endocrinol Metab; 2015 Nov; 309(10):E829-39. PubMed ID: 26394662
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic β-cell dysfunction, expression of iNOS and the effect of phosphodiesterase inhibitors in human pancreatic islets of type 2 diabetes.
Muhammed SJ; Lundquist I; Salehi A
Diabetes Obes Metab; 2012 Nov; 14(11):1010-9. PubMed ID: 22687049
[TBL] [Abstract][Full Text] [Related]
6. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
[TBL] [Abstract][Full Text] [Related]
7. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
8. Effects of pharmacological inhibition of NADPH oxidase or iNOS on pro-inflammatory cytokine, palmitic acid or H2O2-induced mouse islet or clonal pancreatic β-cell dysfunction.
Michalska M; Wolf G; Walther R; Newsholme P
Biosci Rep; 2010 Dec; 30(6):445-53. PubMed ID: 20178457
[TBL] [Abstract][Full Text] [Related]
9. Double-stranded RNA inhibits beta-cell function and induces islet damage by stimulating beta-cell production of nitric oxide.
Heitmeier MR; Scarim AL; Corbett JA
J Biol Chem; 1999 Apr; 274(18):12531-6. PubMed ID: 10212230
[TBL] [Abstract][Full Text] [Related]
10. Impaired glucose-stimulated insulin secretion in the GK rat is associated with abnormalities in islet nitric oxide production.
Mosén H; Ostenson CG; Lundquist I; Alm P; Henningsson R; Jimenez-Feltström J; Guenifi A; Efendic S; Salehi A
Regul Pept; 2008 Nov; 151(1-3):139-46. PubMed ID: 18662725
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide synthase isoforms in glucose-stimulated insulin release.
Henningsson R; Salehi A; Lundquist I
Am J Physiol Cell Physiol; 2002 Jul; 283(1):C296-304. PubMed ID: 12055099
[TBL] [Abstract][Full Text] [Related]
12. Physiological concentrations of interleukin-6 directly promote insulin secretion, signal transduction, nitric oxide release, and redox status in a clonal pancreatic β-cell line and mouse islets.
da Silva Krause M; Bittencourt A; Homem de Bittencourt PI; McClenaghan NH; Flatt PR; Murphy C; Newsholme P
J Endocrinol; 2012 Sep; 214(3):301-11. PubMed ID: 22761278
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products impair glucose-induced insulin secretion from rat pancreatic β-cells.
Hachiya H; Miura Y; Inoue K; Park KH; Takeuchi M; Kubota K
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):134-41. PubMed ID: 23798335
[TBL] [Abstract][Full Text] [Related]
14. Metformin Ameliorates Dysfunctional Traits of Glibenclamide- and Glucose-Induced Insulin Secretion by Suppression of Imposed Overactivity of the Islet Nitric Oxide Synthase-NO System.
Lundquist I; Mohammed Al-Amily I; Meidute Abaraviciene S; Salehi A
PLoS One; 2016; 11(11):e0165668. PubMed ID: 27820841
[TBL] [Abstract][Full Text] [Related]
15. Importance of NADPH oxidase-mediated redox signaling in the detrimental effect of CRP on pancreatic insulin secretion.
Chan PC; Wang YC; Chen YL; Hsu WN; Tian YF; Hsieh PS
Free Radic Biol Med; 2017 Nov; 112():200-211. PubMed ID: 28778482
[TBL] [Abstract][Full Text] [Related]
16. Double-stranded RNA-dependent protein kinase is not required for double-stranded RNA-induced nitric oxide synthase expression or nuclear factor-kappaB activation by islets.
Blair LA; Heitmeier MR; Scarim AL; Maggi LB; Corbett JA
Diabetes; 2001 Feb; 50(2):283-90. PubMed ID: 11272138
[TBL] [Abstract][Full Text] [Related]
17. Mutated ATP synthase induces oxidative stress and impaired insulin secretion in beta-cells of female BHE/cdb rats.
Saleh MC; Fatehi-Hassanabad Z; Wang R; Nino-Fong R; Wadowska DW; Wright GM; Harper ME; Chan CB
Diabetes Metab Res Rev; 2008; 24(5):392-403. PubMed ID: 18273840
[TBL] [Abstract][Full Text] [Related]
18. Hyperuricemia causes pancreatic β-cell death and dysfunction through NF-κB signaling pathway.
Jia L; Xing J; Ding Y; Shen Y; Shi X; Ren W; Wan M; Guo J; Zheng S; Liu Y; Liang X; Su D
PLoS One; 2013; 8(10):e78284. PubMed ID: 24205181
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide inhibits, and carbon monoxide activates, islet acid alpha-glucoside hydrolase activities in parallel with glucose-stimulated insulin secretion.
Mosén H; Salehi A; Henningsson R; Lundquist I
J Endocrinol; 2006 Sep; 190(3):681-93. PubMed ID: 17003269
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitric oxide synthase activity by early and advanced glycation end products in cultured rabbit proximal tubular epithelial cells.
Verbeke P; Perichon M; Friguet B; Bakala H
Biochim Biophys Acta; 2000 Nov; 1502(3):481-94. PubMed ID: 11068190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
